Prosight Management, LP - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 90 filers reported holding REATA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Prosight Management, LP ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$1,497,000
-86.6%
12,112
-89.4%
0.69%
-87.0%
Q3 2020$11,160,000
-12.9%
114,554
+39.5%
5.31%
-3.5%
Q2 2020$12,809,000
+18.3%
82,100
+9.5%
5.50%
+8.6%
Q1 2020$10,826,000
-15.8%
75,000
+19.2%
5.06%
-10.4%
Q4 2019$12,859,000
+155.9%
62,900
+0.5%
5.65%
+102.6%
Q3 2019$5,025,000
-57.4%
62,591
-49.9%
2.79%
-53.1%
Q2 2019$11,790,000
-21.5%
124,965
-28.9%
5.94%
-9.5%
Q1 2019$15,017,000
+5.8%
175,700
-30.6%
6.57%
-10.3%
Q4 2018$14,193,000
+116.6%
253,000
+215.6%
7.33%
+100.5%
Q3 2018$6,553,000
+125.5%
80,155
-3.5%
3.65%
+71.5%
Q2 2018$2,906,000
-52.4%
83,094
-72.1%
2.13%
-44.4%
Q1 2018$6,107,000
+24.7%
297,750
+72.2%
3.83%
+6.4%
Q4 2017$4,896,000172,8973.60%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders